Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 12,128

Document Document Title
WO/2023/068123A1
Silicone-modified pullulan characterized by being an addition reaction product of component (a) and component (b), where (a) is a pullulan having a moisture content of 1.0 mass% or less and a calcium content of less than 100 ppm, and (b)...  
WO/2023/069870A1
Fluid contaminants may be prevalent in many industries, such as the mining industry. Functionalized saccharide polymers comprising two or more monosaccharide units linked by glycosidic bonds and having a portion of the monosaccharide uni...  
WO/2023/066163A1
The present invention relates to the field of food processing. Disclosed are an exopolysaccharide separated from Lactobacillus delbrueckii and Streptococcus thermophilus fermented yoghourt and an application thereof. The neutral exopolys...  
WO/2023/065439A1
The present invention relates to the cross-technical fields of medicine, material chemistry, glycobiology and the like, in particular to a sulfonated hyaluronic acid compound, a preparation method therefor and an application thereof. The...  
WO/2023/065541A1
Disclosed in the present invention are a composite material with a rapid blood coagulation effect and a preparation method therefor, which belong to the technical field of biomedicine. The composite material with the rapid blood coagulat...  
WO/2023/062129A1
The invention pertains to a sugar beet pectin comprising at least 12 wt% protein, based on the total weight of the sugar beet pectin.  
WO/2023/061065A1
The present invention provides a process for extracting pullulan polysaccharide from high-viscosity fermentation broth. The process comprises the following steps: (1) removing thalli from the fermentation broth; (2) removing protein; (3)...  
WO/2023/060671A1
A traditional Chinese medicine polysaccharide feed additive, and a preparation method therefor and the use thereof. The additive consists of the following components in parts by weight: 5-10 parts of lactoferrin, 3-5 parts of medium-chai...  
WO/2023/062185A1
The invention provides a method of preparing a biocompatible hydrogel, a hydrogel obtainable by said method, a biocompatible hydrogel for non-covalent immobilization of one or more enzyme(s), and a composition comprising any of said hydr...  
WO/2023/059499A1
The present invention includes a method for the preparation of chitin nanocrystals, nanowhiskers, or both directly from a raw chitinous biomass without the prior isolation of a raw chitin polymer using an ionic liquid comprising: drying ...  
WO/2023/056996A1
The present invention refers to a method and device for the preparation of microfibres and nanofibres based on hyaluronic acid and/or a water-soluble metal or non-metal salt thereof or a mixture of salts and/or a derivative of hyaluronic...  
WO/2023/057712A1
The present invention relates to the field of compositions comprising a polymer bearing a chelating group capable of chelating one or more metals, and to the various uses thereof. In particular, the present invention relates to compositi...  
WO/2023/055307A1
A method for extracting Hevea Latex Polysaccharides (HLPs) from process effluent in the rubber manufacturing industry. The effluent obtained from the squeeze-milling of rubber coagula is optionally filtered in order to remove debris and ...  
WO/2023/048126A1
The present invention addresses the problem of providing, for example: an EPS manufacturing method in which EPS productivity is improved; EPS which is manufactured using the manufacturing method; a manufacturing method for fermented prod...  
WO/2023/049727A1
The invention relates to substituted cyclodextrin (CD) compounds having C9 to C25 optionally substituted alkyl-based linker groups, which irreversibly inhibit viruses and are useful in the treatment of viral infections. While the compoun...  
WO/2023/047790A1
One purpose of the present invention is to provide a production method of a cyclic oligosaccharide by which a cyclic oligosaccharide can be efficiently synthesized. Another purpose of the present invention is to provide a novel cyclic ol...  
WO/2023/049167A1
The present disclosure provides a process for preparing glycated chitosan and compositions comprising glycated chitosan.  
WO/2023/041836A1
The present invention relates to a hydrogel precursor composition and to a bioink obtainable from the hydrogel precursor composition, as well as a method of preparing and using the same. More specifically, the invention relates to a bioi...  
WO/2023/040033A1
The present invention relates to the technical field of preparation of food and cosmetic raw materials. Disclosed are an anti-oxidant repair Ganoderma lucidum extract and a preparation method therefor. The preparation method comprises: m...  
WO/2023/039024A1
A method for isolating lignin and synthesizing nanocellulose from lignocellulosic materials is provided. The method describes crushing and grinding the lignocellulosic material under pressure with a solid acid catalyst to induce a solid-...  
WO/2023/036203A1
A Cs-4 fermented mycelium heteropolysaccharide, a preparation method therefor and a use thereof. The polysaccharide structure is shown below, where N is selected from 6-104. The polysaccharide can be used for preventing or treating chron...  
WO/2023/036219A1
Provided in the present invention are a homogalacturonan, a complex, and a preparation method therefor and the use thereof. Provided in the present invention is a preparation method for homogalacturonan, comprising the following steps: s...  
WO/2023/034881A1
The present disclosure relates to mRNA, self-replicating RNA, and temperature-sensitive, self-replicating RNA encoding a cancer antigen. The RNA constructs are suitable for cancer immunotherapy in a mammalian subject, such as a human sub...  
WO/2023/033276A1
The present invention relates to a pharmaceutical composition comprising a gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related disease, and a use thereof. A pharmaceutical composition comprising...  
WO/2023/027330A1
The present invention relates to a hyaluronic acid (HA) filler composition using polyethylene glycol (PEG) and glycolic acid (GA) as crosslinking agents and a method for preparing same. The present invention is characterized by preparati...  
WO/2023/025943A1
A diblock polymer comprising a first component covalently bound via a linker to a second component; wherein said first component is an oligomer comprising at least 50 mol% L-guluronic acid residues and having a degree of polymerisation n...  
WO/2023/026010A1
The invention relates to a method for preparing a mixture of poorly-digestible alpha-glucans from a substrate rich in oligosaccharides having a degree of polymerisation (DP) of 4.  
WO/2023/022554A1
The present invention provides a method for preparing a swellable polymer to which an object is fixed. The preparation method of the present invention comprises a step of absorbing a solution of an object, which is dissolved or dispersed...  
WO/2023/023648A1
Compositions and methods are disclosed for enhancing the bioavailability and/or increasing the stability of at least one agent by modifying the at least one agent with cyclodextrin. Pharmaceutical compositions including the cyclodextrin-...  
WO/2023/019987A1
The present invention belongs to the field of food processing, and discloses a neutral exopolysaccharide of lactobacillus plantarum and the use thereof. The neutral exopolysaccharide of lactobacillus plantarum of the present invention is...  
WO/2019/080950A9
The invention relates to a solvent-free polymer electrolyte for use in a rechargeable lithium-ion secondary battery, comprising a polymer matrix which is conductive for lithium-ions and a lithium salt. The polymer matrix has at least one...  
WO/2023/012115A1
The present invention relates to an active ingredient comprising oligo-glucans, obtained from the cytosolic fraction of a yeast of the species Saccharomyces cerevisiae, a cosmetic composition containing same and cosmetic uses thereof, in...  
WO/2023/013426A1
[Problem] To provide: a crosslinked EPDM composition which enables the re-dissolution of a polyrotaxane having a hydrosilyl group in a primary solvent after solidification and therefore enables the handling of the polyrotaxane in a solid...  
WO/2023/011639A1
Provided in the present invention are a class of new oligosaccharide linkers and a linking method. By taking a conserved glycosylation site on an antibody as a coupling site, a biantennary oligosaccharide as a linker structure, and struc...  
WO/2023/012333A2
The present invention is directed to gels, cryogels and other polymer scaffolds, solid surfaces, aggregates, films and coatings comprising a soluble chemically modified cross-linked chitosan useful for 3D cell and organoid bioprinting an...  
WO/2023/006108A1
The present invention provides a preparation method for sodium hyaluronate having full molecular weight distribution, the method comprising: step 1): spraying hydrogen peroxide and performing ultraviolet irradiation on a sodium hyalurona...  
WO/2023/004456A1
Described herein is an isolated biological polysaccharide compound. The biological polysaccharide compound may be characterised by being isolated and having: glycosyl linkages comprising 1:3 linked glucopyranosyl residue of 65-95%wt and ...  
WO/2023/001913A1
The present invention relates to chitosan oligomers obtainable by enzymatic hydrolysis of chitosan polymers, compositions containing them, and uses thereof.  
WO/2023/002959A1
Provided are: a chitosan derivative which has an excellent emulsification ability and a high salt-forming rate, and from which it is possible to prepare an emulsification composition such as a highly stable milky lotion by finely dispers...  
WO/2023/285663A1
The present invention provides a hydroxypropyltrialkylammonium hyaluronate and/or salt thereof, having a degree of cationization of more than 1.4.  
WO/2023/287366A1
This invention relates to a method for preparing hyaluronic acid grafted poly(N-isopropylacrylamide) (HA-g-pNIPAM) comprising the steps of: a) preparing a mixture comprising hyaluronic compound, poly(N-isopropylacrylamide) and carbodiimi...  
WO/2023/287684A1
Compositions are disclosed herein comprising an ester derivative of a glucan, wherein the glucan has a degree of substitution (DoS) up to about 3.0 with at least one cationic organic group that is ester-linked to the glucan. Methods are ...  
WO/2023/287348A1
A method for the manufacture of agar or agarose beads, the method comprising the steps of: i) providing a water phase comprising an aqueous solution of agar or agarose at a temperature above the gelling temperature of said aqueous soluti...  
WO/2023/280235A1
The present invention relates to a heparin molecule containing an AT binding sequence and a continuous 2-O-glucuronic acid residue, and a preparation method therefor and the use thereof. The heparin molecule contains an AT binding sequen...  
WO/2023/282413A1
The present invention relates to a homogeneous spherical hyaluronic acid bead gel having a swelling degree of 4,500%-10,000%, which is prepared through a mixed crosslinking reaction step, a second step of crosslinking reaction of a dispe...  
WO/2023/280084A1
The present invention relates to the field of anticoagulant and antithrombotic drugs, and in particular to an application of sulfate gluco-galacto-oligosaccharide in preparation of an anticoagulant and/or antithrombotic drug. Disclosed i...  
WO/2023/281262A1
The invention provides a method for obtaining alginate from macroalgae, in particular from brown seaweed such as Laminaria hyperborea. It further relates to alginate obtained by such a method. More particularly, the invention provides a ...  
WO/2023/283532A1
The present disclosure provides for a method of purifying rubber from a plant that naturally produces rubber, the method including: a) contacting plant material with hot water or a dilute basic aqueous solution, thereby forming a plant m...  
WO/2023/274748A1
A biomedical device is disclosed. The biomedical device includes a polymerization product of a biomedical device-forming mixture containing (a) one or more grafted glycosaminoglycan polymers including a glycosaminoglycan having a polymer...  
WO/2023/278631A1
Provided herein are methods of producing heparin and heparan sulfate from modified cells, such as modified MST cells, and compositions comprising heparin and heparan sulfate isolated from modified cells.  

Matches 201 - 250 out of 12,128